MDXG
MiMedx Group, Inc.
NASDAQ · Healthcare · Biotechnology · US
$4.57
+3.16%Price chart
Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4
ValuationView details →
P/E (Fwd)
107.5x
EV/EBITDA
22.4x
Market Cap
$666.13M
MomentumView details →
1D Return
+3.16%
YTD Return
−33.16%
RSI (14)
58.7
ValuationView details →
P/E (Fwd)
107.5x
EV/EBITDA
22.4x
Market Cap
$666.13M
RSI (14)
58.7
MomentumView details →
1D Return
+3.16%
YTD Return
−33.16%
SummaryUpdated Jun 1, 2026
MiMedx Group, Inc. (NASDAQ:MDXG) is a biotechnology company founded in 2008 and headquartered in Marietta, Georgia. The company specializes in developing and distributing placental tissue allografts for various healthcare applications. MiMedx has established itself as a leader in the regenerative medicine space, processing human placental tissues through its proprietary PURION process to create biological products that retain the tissue's natural healing properties. The company has evolved from its early focus on wound care into a diversified portfolio serving surgical recovery, burn treatment, and other medical applications.
Similar companies
Latest newsMore news →
Sanara MedTech Inc. agreed to be acquired by MiMedx Group, Inc. for $33.00 in cash and 0.4735 shares of MiMedx common stock per Sanara share.7d agoMiMedx Group reported second quarter 2026 net sales of $64 million and reiterated its full year financial outlook on a standalone basis.37d agoMiMedx Group announced it will acquire Sanara MedTech in a cash and stock transaction valued at $35 per share with a total enterprise value of approximately $350 million.37d ago